Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
Mexican police investigate body found outside Tijuana stadium where Iran prepares for World Cup
Mexican authorities are investigating how a corpse ended up...
Albuquerque man charged in antisemitic attacks on Jewish properties
WITH A TRIAL SCHEDULED FOR MAY 2027. SERIOUS TROUBLE...
Socceroos vs. Türkiye recap: Australia joins USMNT atop Group D
ESPNMultiple AuthorsJun 14, 2026, 02:05 AM ETEmailPrintOpen Extended ReactionsVANCOUVER...